Welcome to Broadcom Inc.'s First Quarter Fiscal Year 2026 Financial Results Conference Call. At this time, for opening remarks and introductions, I would like to turn the call over to Ji Yoo, Head of ...
Shareholder/Analyst Call March 4, 2026 11:00 AM ESTCompany ParticipantsRichard William Fairman - CEO & DirectorRobin Alfonso - ...
Citius Oncology, Inc. ("Citius Oncology") , an oncology?focused biopharmaceutical company and majority?owned subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") , today announced positive ...
The 44th meeting of the Emergency Committee under the International Health Regulations (IHR or Regulations) on the international spread of poliovirus ...
The group that makes recommendations on preventive health care services has not met in a year, and this latest meeting has not been rescheduled. Meanwhile, the Camp East Montana immigration facility ...
Quarterly net loss -- $1.5 million, or $0.07 per diluted share, compared to $1.2 million, or $0.06 per share, the previous ...
Six months ago, in July 2025, we published a blog post providing a brief history of noncompete agreements in the United ...
Detailed price information for Quidelortho Corp (QDEL-Q) from The Globe and Mail including charting and trades.
Fairway Capital Management announced today that Fairway Private Equity & Venture Capital Opportunities Fund increased in Net ...
Deep mutational scanning reveals pharmacologically relevant insights into TYK2 signaling and disease
This important paper presents a rigorous and comprehensive deep mutational analysis of the kinase TYK2, revealing how single amino acid substitutions influence protein abundance, signaling activity, ...
Topline data of investigator-initiated study at the University of Minnesota and City of Hope demonstrates 86% overall response rate (OR), including 57% complete response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results